$GALT News Article - Galectin Therapeutics Provide
Post# of 61
(Total Views: 195)
Posted On: 03/02/2023 11:30:50 AM
$GALT News Article - Galectin Therapeutics Provides Final Randomization Status of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis https://marketwirenews.com/news-releases/gale...65026.html
(0)
(0)Galectin Therapeutics Inc (GALT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼